CERS
Price
$1.34
Change
+$0.03 (+2.29%)
Updated
Jun 18 closing price
Capitalization
342.62M
42 days until earnings call
RCEL
Price
$5.25
Change
+$0.04 (+0.77%)
Updated
Jun 18 closing price
Capitalization
399.48M
49 days until earnings call
Interact to see
Advertisement

CERS vs RCEL

Header iconCERS vs RCEL Comparison
Open Charts CERS vs RCELBanner chart's image
Cerus
Price$1.34
Change+$0.03 (+2.29%)
Volume$805.59K
Capitalization342.62M
Avita Medical
Price$5.25
Change+$0.04 (+0.77%)
Volume$152.3K
Capitalization399.48M
CERS vs RCEL Comparison Chart in %
Loading...
CERS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RCEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CERS vs. RCEL commentary
Jun 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CERS is a Hold and RCEL is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 19, 2025
Stock price -- (CERS: $1.34 vs. RCEL: $5.25)
Brand notoriety: CERS and RCEL are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: CERS: 69% vs. RCEL: 57%
Market capitalization -- CERS: $342.62M vs. RCEL: $399.48M
CERS [@Medical Specialties] is valued at $342.62M. RCEL’s [@Medical Specialties] market capitalization is $399.48M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.56B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CERS’s FA Score shows that 0 FA rating(s) are green whileRCEL’s FA Score has 0 green FA rating(s).

  • CERS’s FA Score: 0 green, 5 red.
  • RCEL’s FA Score: 0 green, 5 red.
According to our system of comparison, CERS is a better buy in the long-term than RCEL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CERS’s TA Score shows that 4 TA indicator(s) are bullish while RCEL’s TA Score has 4 bullish TA indicator(s).

  • CERS’s TA Score: 4 bullish, 5 bearish.
  • RCEL’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, RCEL is a better buy in the short-term than CERS.

Price Growth

CERS (@Medical Specialties) experienced а -5.63% price change this week, while RCEL (@Medical Specialties) price change was -13.37% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -2.92%. For the same industry, the average monthly price growth was -0.51%, and the average quarterly price growth was +1.32%.

Reported Earning Dates

CERS is expected to report earnings on Jul 31, 2025.

RCEL is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Medical Specialties (-2.92% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RCEL($399M) has a higher market cap than CERS($343M). CERS YTD gains are higher at: -12.987 vs. RCEL (-58.984). CERS has higher annual earnings (EBITDA): -26.34M vs. RCEL (-33.54M). RCEL has more cash in the bank: 89.1M vs. CERS (65.9M). RCEL has less debt than CERS: RCEL (42.4M) vs CERS (96M). CERS has higher revenues than RCEL: CERS (156M) vs RCEL (50.1M).
CERSRCELCERS / RCEL
Capitalization343M399M86%
EBITDA-26.34M-33.54M79%
Gain YTD-12.987-58.98422%
P/E RatioN/AN/A-
Revenue156M50.1M311%
Total Cash65.9M89.1M74%
Total Debt96M42.4M226%
FUNDAMENTALS RATINGS
CERS vs RCEL: Fundamental Ratings
CERS
RCEL
OUTLOOK RATING
1..100
7856
VALUATION
overvalued / fair valued / undervalued
1..100
44
Fair valued
65
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
97100
PRICE GROWTH RATING
1..100
8094
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CERS's Valuation (44) in the Medical Specialties industry is in the same range as RCEL (65) in the null industry. This means that CERS’s stock grew similarly to RCEL’s over the last 12 months.

CERS's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as RCEL (100) in the null industry. This means that CERS’s stock grew similarly to RCEL’s over the last 12 months.

CERS's SMR Rating (97) in the Medical Specialties industry is in the same range as RCEL (100) in the null industry. This means that CERS’s stock grew similarly to RCEL’s over the last 12 months.

CERS's Price Growth Rating (80) in the Medical Specialties industry is in the same range as RCEL (94) in the null industry. This means that CERS’s stock grew similarly to RCEL’s over the last 12 months.

CERS's P/E Growth Rating (100) in the Medical Specialties industry is in the same range as RCEL (100) in the null industry. This means that CERS’s stock grew similarly to RCEL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CERSRCEL
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
74%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
73%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
76%
MACD
ODDS (%)
Bearish Trend 1 day ago
84%
Bullish Trend 1 day ago
74%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
75%
Bearish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 17 days ago
76%
N/A
Declines
ODDS (%)
Bearish Trend 7 days ago
84%
Bearish Trend 3 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
86%
Aroon
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
CERS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RCEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TIIRX26.35N/A
N/A
Nuveen Core Equity A
GTSIX30.52N/A
N/A
Invesco Small Cap Growth Inv
HIISX15.74N/A
N/A
Harbor International Small Cap Investor
VEUVX38.46N/A
N/A
JPMorgan Europe Dynamic R6
HEMIX10.05-0.01
-0.10%
Janus Henderson Emerging Markets I

CERS and

Correlation & Price change

A.I.dvisor indicates that over the last year, CERS has been loosely correlated with LAB. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if CERS jumps, then LAB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CERS
1D Price
Change %
CERS100%
+2.29%
LAB - CERS
53%
Loosely correlated
+6.86%
NNOX - CERS
47%
Loosely correlated
-0.20%
SGHT - CERS
47%
Loosely correlated
+5.96%
BFLY - CERS
46%
Loosely correlated
-1.82%
ICUI - CERS
45%
Loosely correlated
-1.07%
More

RCEL and

Correlation & Price change

A.I.dvisor indicates that over the last year, RCEL has been loosely correlated with MRCHF. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if RCEL jumps, then MRCHF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RCEL
1D Price
Change %
RCEL100%
+0.77%
MRCHF - RCEL
38%
Loosely correlated
N/A
GMED - RCEL
36%
Loosely correlated
-1.32%
MBOT - RCEL
34%
Loosely correlated
+2.07%
CTKB - RCEL
34%
Loosely correlated
-3.76%
CERS - RCEL
33%
Loosely correlated
+2.29%
More